Health Grants in Australia (All States) — 2026

The objective of the Ideas Grant scheme is to support innovative research projects addressing specific question(s). The expected outcomes are: • innovative and creative research • funding of researchers at all career stages • funding any area of health and medical research from discovery to implementation. It is expected that the CIA will have the capability to lead the team in achieving the project aims. Only applications that address the intended objective and outcomes will be competitive for funding. The Ideas Grant scheme is not intended to support research where a clinical trial or cohort study is the primary objective, and applications meeting that description should be submitted to the Clinical Trial and Cohort Studies Grant scheme. Where applications have elements consistent with both the Clinical Trials and Cohort Studies Grant scheme and the Ideas Grant scheme, applicants should decide where the project is predominantly suited, based on the objectives and intended outcomes of

A venture capital investment program that provides capital and professional expertise to innovative Australian early-stage companies and high-growth startups. The program offers increased fund sizes up to $200 million, a 10% tax offset on capital deployed into start-up companies, and a tax-exempt environment for investment returns.

A legislated tax offset program that supports companies to invest in eligible research and development by offsetting some of the associated costs. The program provides refundable or non-refundable tax offsets based on company turnover and R&D expenditure proportions, with offsets up to $150 million.

Partnership Projects will support collaborations, within the Australian context, that translate research evidence into health policy and health practice, to improve health services and processes. The objectives of the Partnership Project scheme are to: • Meet the need for more effective integration of research evidence into health policy and service delivery • Create partnerships among policy makers, managers, service providers and researchers • Provide support to answer often complex and difficult questions that policy makers, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care • Be highly responsive to the priorities of government, the community and health professionals • Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations. Eligibility: Appications will only be accepted from NHMRC approved Administering Institut

Grants to support medical research and medical innovation projects through the establishment of BioMedTech Incubators. The program funds eligible organisations to identify, select and support Australian SMEs undertaking early-stage medical research and innovation projects with commercial potential in areas such as biomarkers, diagnostics, therapeutics, assistive devices and digital technologies.

This grant program supports researchers pursuing innovative projects to develop new products and interventions in health and medical research, with the goal of creating treatments for serious and incurable health conditions. Funding supports programs of research comprising linked projects with a 10-year time horizon, from proof-of-concept through to full clinical implementation.

A $10 million research funding initiative supporting high-quality research into the health and wellbeing of serving and ex-serving Australian Defence Force members. The program aims to generate evidence and develop practical, implementable actions to improve mental and physical health outcomes, with consideration for support networks including family, dependants and carers. Research must focus on translation and implementation, prevention and early intervention strategies, and collaborative multidisciplinary approaches.

This grant program provides financial assistance to support medical research and medical innovation projects focused on genomics and precision medicine. It funds six streams of research including development of genomic tools for cancer screening, gene discovery research, polygenic risk score methods for disease identification, clinical genomics implementation, and research infrastructure for data sharing and collaboration across Australia.

Living organ donation is major surgery and carries risk for the donor. Prospective donors undergo extensive work-up testing to ensure they are physically and mentally able to donate, and these medical appointments may require donors to take time off work. If donation surgery proceeds, donors may require a significant amount of time off work to recover. The extensive work-up testing and donation surgery may require donors to travel long distances for medical appointments. The program aims to ensure that taking time off work and out-of-pocket travel and accommodation expenses are not a barrier for individuals considering donation. The program provides reimbursement of paid leave and out-of-pocket expenses associated with donation. The program is not an incentive to donate. It is designed to help support those individuals who wish to donate but cannot afford to due to loss of income and the financial stress it would cause for them and their family. The purpose of the program is to reduce

The 2026 NHMRC-Swiss National Science Foundation (SNSF) grant opportunity supports Australian participation in an international collaboration with Switzerland through the Australian - Swiss Joint Research Programme Call for Proposals 2026. NHMRC is working with SNSF to support Joint Research Projects to promote collaborative projects with clearly defined goals, involving at least one partner based in Switzerland and one based in Australia. The research field for this collaboration is: Artificial Intelligence (AI) in healthcare for populations of diverse sex, gender or sexual orientations or other underrepresented population groups. Applicants are required to justify how their target population is considered underrepresented in the context of this funding opportunity. Possible topics include but are not limited to: • AI for medical decision support for diagnosis and treatment planning, with a focus of underrepresented population groups • Addressing bias in medical training data • Enhanc

This grant funds implementation research that maximizes collaboration and coordination with sectors and settings beyond the healthcare system to tackle chronic non-communicable diseases in low- and middle-income countries and/or underserved populations in high-income countries. For Australian funding, research must focus on Aboriginal and/or Torres Strait Islander communities. The grant supports strategies leveraging opportunities provided by settings and sectors beyond the health system while facilitating collaboration with relevant healthcare systems.

This grant supports implementation research that maximizes collaboration across sectors and settings beyond the healthcare system to address chronic non-communicable diseases in underserved populations. Proposals should focus on strategies leveraging opportunities in low- and middle-income countries (LMICs) and/or for Aboriginal and Torres Strait Islander communities in Australia, with expected collaboration from relevant healthcare systems.

A collaborative funding opportunity between NHMRC and the Swiss National Science Foundation supporting joint research projects addressing artificial intelligence in healthcare for underrepresented population groups. The program funds Australia-based researchers participating in transnational consortia to develop solutions that mitigate biases in AI healthcare applications through diverse training datasets, evaluation mechanisms, inclusive data governance, and culturally informed protocols.

The 2026 NHMRC-European Partnership for Brain Health (EP BrainHealth) Grant Opportunity supports Australian participation and collaboration in transnational research projects through European Partnership for Brain Health (EP BrainHealth) Call for Proposals. The EP BrainHealth offers 2 calls: one in the field of neurological, mental disorders and sensory disorders (EP BrainHealth Call 1) and one in the field of neurodegenerative disorders (EP BrainHealth Call 2). Further information on the EP BrainHealth Call for Proposals is available from the EP BrainHealth website. Eligibility: Applications will only be accepted from NHMRC approved Administering Institutions. • Australia-based researchers must submit an application at the full proposal stage to both NHMRC and the EP BrainHealth Secretariat to be considered for 2026 NHMRC-EP BrainHealth funding. A copy of the full proposal as submitted to EP BrainHealth must be included in the 2026 NHMRC-EP BrainHealth application for funding. • The C

The 2025 NHMRC-Horizon Europe grant opportunity supports Australian participation in international collaborative research under Horizon Europe. Horizon Europe facilitates collaboration and strengthens research impact and innovation while tackling global challenges. NHMRC will invite Australia-based researchers who are listed on eligible applications deemed fundable by the European Commission (EC) to apply to NHMRC for support of the Australian component of research under the following topics submitted under the Horizon Europe topics listed in section 2.4 of the 2025 NHMRC-Horizon Europe Guidelines. Applicants should note that the topics are listed either under a single stage deadline model or a two-stage deadline model and have different submission dates: Single stage deadline model – 29 April 2026 Two-stage deadline model – 25 November 2026 Eligibility: Applications will only be accepted from NHMRC approved Administering Institutions. A list of NHMRC approved Administering Institution

NHMRC is providing up to $4 million to support Australia-based researchers participating as partners in transnational consortia through the European Partnership for Brain Health. The funding supports research projects on biological, social and environmental factors that impact the trajectory of brain health across the lifespan, with two calls covering neurological/mental/sensory disorders and neurodegenerative disorders.

The 2026 NHMRC-Horizon Europe grant opportunity supports Australian participation in international collaborative research under Horizon Europe. Horizon Europe facilitates collaboration and strengthens research impact and innovation while tackling global challenges. NHMRC will invite Australia-based researchers who are listed on eligible applications deemed fundable by the European Commission (EC) to apply to NHMRC for support of the Australian component of research under the following topics submitted under the Horizon Europe topics listed in section 2.4 of the 2026 NHMRC-Horizon Europe Guidelines. Eligibility: Applications will only be accepted from NHMRC approved Administering Institutions. Applications must satisfy all the requirements set out in the 2026 NHMRC-Horizon Europe Guidelines. Grant Activity Timeframe: Up to 5 years Total Amount Available (AUD): $4,000,000.00 Estimated Grant Value (AUD): From $0.00 to $500,000.00 Instructions for Application Submission: Applications must

This program provides funding to establish and extend infrastructure of critical importance for conducting world-class health and medical research in areas of unmet medical need. It supports four streams: innovation enablers, digitisation of health care, co-investment partnerships, and mRNA technology enablers.

This grant supports medical research and innovation projects that promote Australian involvement in international collaborative investigator-initiated clinical trials. It aims to increase clinical trial activity in Australia by establishing and coordinating clinical trial sites, providing high-quality evidence of novel health treatments, drugs, or devices in usual care settings.

CRC-P Grants provide matched funding of $100,000 to $3 million for short-term (up to 3 years) industry-led research collaborations. Projects must develop a product, service or process that solves industry problems and benefits SMEs, with eligible costs including new research, proof of concept, pre-commercialisation, and industry-focused education.

This grant supports medical research and innovation projects investigating Post-Acute Sequelae of COVID-19 (PASC) across four streams: biological pathway investigation, pre-clinical and early-phase clinical research, comparative studies of biological drivers, and large-scale evaluation of integrated care pathways. All applications must demonstrate meaningful co-design with consumers and reflect the complexity and heterogeneity of PASC.

A $10 million research funding opportunity to support high-quality evidence generation and practical, implementable actions to improve mental and physical health and wellbeing among serving and ex-serving ADF members. The grant focuses on translation and implementation, prevention and early intervention strategies, and collaborative multidisciplinary research approaches that address complex intersecting health needs and support networks including family and carers.

This grant provides financial assistance to support medical research and medical innovation projects that are consumer-led and co-designed. It includes two streams: an Incubator stream for identifying health priorities and conducting pilot studies, and a Targeted Call for Research stream for developing scalable approaches to self-care interventions and improving quality of life. Research topics focus on cancer, long-term physical diseases, or mental health challenges.

This grant supports medical research and medical innovation projects aimed at improving outcomes for Australians with traumatic brain injury (TBI). Two streams are available: Stream 1 focuses on testing novel treatments and interventions for moderate to severe TBI, while Stream 2 supports research on implementing clinical guidelines and protocols for mild TBI with attention to equity and access across diverse populations.

This funding scheme supports collaborations between researchers and policy makers to define research questions, undertake research, interpret findings, and implement results into policy and practice. Partnership Projects answer specific research questions to influence health and well-being through changes in the delivery, organisation, funding and access to health services.

This funding scheme supports collaborations between researchers and policy makers to define research questions, undertake research, interpret findings, and implement results into policy and practice. Partnership Projects address specific research questions to influence health and well-being through changes in the delivery, organisation, funding and access to health services.

The Industry Growth Program awards matched funding grants to high growth potential Australian businesses to commercialise their innovative projects and build Australian manufacturing capability. Grant amounts range from $50,000 up to $5 million, assessed on merit by an independent committee. Participants receive an Advisory Service report before applying for the matched funding grant opportunity.

The Industry Growth Program provides access to specialist expertise and networks to support early-stage startups in developing and growing their companies locally and globally. The program offers advisory services and grants to help innovative companies scale their operations and achieve market adoption.

A $5 million grant to support EMVision's expansion of their team and clinical studies for their First Responder portable brain scanner device. The funding also supports setting up a pilot production line in Sydney for export of the device globally.

This program provides funding for business events such as expos, trade shows, forums, and conferences that promote Western Australia as a destination for trade and investment. Events can be hybrid, virtual, or in-person and must strengthen connections between WA and international markets of strategic importance.

The MDPP supports inventors from research, industry and clinical settings to develop new medical devices and assistive technologies through early-stage development. Participants receive up to 250 hours of technical expertise including research, proof of concept, prototyping, product validation, and introductions to potential manufacturers and commercial partners.

This program provides NSW small to medium enterprises with support measures to help them attain new business in targeted global markets. Participants receive expert-led workshops, market intelligence briefings, cultural and pitch training, introductions to potential partners and buyers, and in-market visits with specialist staff support.

The National Reconstruction Fund Corporation (NRFC) provides debt finance, equity finance and guarantees for businesses with compelling proposals in priority areas of the Australian economy. Applicants may seek funding for proposals in renewables and low emissions technologies, medical science, transport, value-add in agriculture/forestry/fisheries, value-add in resources, defence capabilities, and enabling capabilities.

The Practice Incentives Program provides funding for general practices to help them continuously improve, provide quality care, enhance capacity and improve access and health outcomes for patients. Payments are available for various activities including eHealth, quality improvement, teaching, aged care access, Indigenous health, after hours care, procedural activities, and rural locations.

The Workforce Incentive Program provides general practices with funding to build a sustainable and high quality health workforce, particularly in rural and remote areas. It supports practices to engage eligible health professionals in promoting preventative health, chronic disease management, and care coordination. Payments include quarterly incentive payments, rural loading of up to 50%, and annual loading for practices serving Veterans' Affairs Gold Card holders.

The CRC Program funds collaborative research between industry, government, and academic partners to develop technologies and solutions for real-world problems. CRC CARE specifically focuses on developing technologies to assess, clean up, and prevent soil, water, and air contamination, with support totaling $56.1 million in Australian Government funding since 2005.

The Cell Therapy Manufacturing Cooperative Research Centre (CTM CRC) is funded by the Australian Government to develop innovative cell therapy manufacturing technologies. The CRC focuses on creating stem cell delivery systems for chronic wound treatment and developing scalable production methods for immune cell therapies used in cancer and other medical conditions.

The Indigenous Advancement Strategy provides funding for organisations to help them undertake projects or activities which promote equal opportunities for Indigenous Australians. The program focuses on 5 key areas: jobs, land and economy; children and schooling; safety and wellbeing; culture and capability; and remote Australia strategies. The Government has committed $5.2 billion over 4 years to the IAS.

The WIP – Doctor Stream provides financial incentives to medical practitioners who deliver eligible primary care services in rural and remote areas of Australia. Payments are made through two systems: the Central Payment System (CPS) for doctors billing the Medicare Benefits Schedule, and the Flexible Payment System (FPS) for doctors providing eligible services or undertaking training not reflected in the MBS. Incentive amounts vary based on activity levels, tenure in the program, and vocational registration status.

A tax incentive program that deems clinical trial activities as core R&D activities eligible for the R&D Tax Incentive. Companies conducting clinical trials registered with the TGA can claim tax benefits for their R&D activities related to these trials.

The VCLP program provides attractive tax benefits for venture capital investors to make early or late stage investments in innovative Australian businesses. It supports the commercialisation of promising technologies developed by Australian research universities and their spin-out companies.

The ITRP supports university researchers to partner with industry in priority areas for Australia. It includes Industrial Transformation Research Hubs that fund research projects focused on issues facing industry, and Industrial Transformation Training Centres that support Higher Degree by Research (HDR) students and postdoctoral researchers to gain practical skills and experience through industry placements.

This grant opportunity supports medical research and medical innovation projects focused on traumatic brain injury. Stream 1 funds research testing novel treatments and interventions for moderate to severe traumatic brain injury to reduce acute care time and improve long-term outcomes. Stream 2 supports research on effective national adoption and best practice use of clinical guidelines for mild traumatic brain injury, including addressing implementation barriers and inequalities across diverse populations.

The NHMRC Postgraduate Scholarships scheme funds successful applicants to attain a research-based postgraduate degree (Doctor of Philosophy or Research Masters Degree). It aims to support outstanding health and medical graduates early in their career to conduct internationally competitive research and develop capacity for original independent research within Australia.

This grant opportunity supports medical research and innovation projects across six streams focused on genomics and health futures, including developing genomic tools for cancer screening, enhancing gene discovery and diagnostic rates, developing polygenic risk score methods, improving clinical genomics implementation, and building data-sharing infrastructure. The funding aims to improve health outcomes for Australians through advances in genomic testing, diagnosis, prevention, and targeted therapies.

This grant supports medical research and innovation projects investigating Post-Acute Sequelae of COVID-19 (PASC), including biological pathways, mechanistic drivers, and clinical interventions. The opportunity includes four streams: three incubator streams focusing on PASC subtypes and comparisons with other post-viral conditions, and one targeted call for large-scale research on integrated care pathways. Funding aims to improve patient care, develop new diagnoses and treatments, and translate discoveries into clinical practice.

This grant supports research co-led with consumers addressing health priorities and barriers, with two streams: Stream 1 (Incubator) for identifying health priorities and conducting pilot studies, and Stream 2 (Targeted Call for Research) for developing scalable approaches to self-care interventions and quality of life improvements. Research focuses on cancer, long-term physical diseases, or mental health conditions affecting individuals with long-term diseases and conditions.

A tax incentive program that deems clinical trial activities as core R&D activities, simplifying application and providing certainty for companies conducting clinical trials. Companies can claim tax benefits on eligible clinical trial expenses when registered with the program.

CRC Grants provide funding for medium to long-term, industry-led research collaborations aimed at solving industry-identified problems and improving competitiveness, productivity and sustainability of Australian industries. Funding covers up to 50% of eligible grant project costs, with applicants required to match the grant funding through cash and/or in-kind contributions.

The Australian Government provides funding to support critical services in remote First Nations communities in the Northern Territory, including remote policing, child and family services, Aboriginal interpreter services, alcohol harm reduction services, education programs, and hearing and oral health services. The program commits $842.6 million over 6 years commencing 1 July 2025 to continue delivery of essential remote services, expand supports for Aboriginal Community Controlled Organisations, enable communities to design and deliver services, and support access to economic development and employment opportunities.

A tax offset program that provides financial support to eligible corporations conducting research and development activities in Australia. Companies can claim tax offsets based on eligible R&D expenditure, with different benefit rates depending on company size and expenditure levels.

The CRC Grants Program funds collaborative research centres that bring together researchers, industry, and other partners to conduct research and development. The program supports multiple active CRCs across various sectors including digital health, agriculture, manufacturing, energy, and environmental solutions, with funding terms typically spanning 10 years.

This grant provides emergency funding to IAHP funded organisations in response to urgent or unforeseen issues that may arise. Approved activities include purchasing necessary equipment to ensure service continuity, targeted funding for emergency health needs, and purchasing or repairing equipment/infrastructure due to natural disasters. The funding is one-off and/or time-limited, not for ongoing projects.

This project aims to apply advances in RNA and peptide chemistry to develop a new generation of precision medicines with potential to modify disease in FacioScapuloHumoral Dystrophy (FSHD). The innovation addresses barriers to systemic delivery, muscle and cell uptake, stability and safety. The project will generate proof of concept for muscle targeting of precision therapeutics in relevant models of FSHD.

The RUIC program connects Queensland-based SMEs with regional universities to help solve technical challenges and progress new ideas through collaborative R&D projects. Eligible SMEs can access up to $50,000 in dollar-matched funding, regional research facilitators for end-to-end support, free R&D training through the Innovate to Grow program, and networking opportunities with innovation experts and investors.

The CRC Grants program funds collaborative research centres that bring together industry, research organizations, and government to develop innovative solutions across various sectors. The program supports multiple CRCs working on challenges ranging from mine closure transformation and hydrogen fuel blending to cybersecurity, manufacturing, agriculture, and healthcare applications.

The ARC Centres of Excellence Program supports high-quality groups of researchers working in areas of national and international importance for Australia. Centres partner with strategic industry and research organisations to undertake innovative and potentially transformational research, develop international networks, and build Australia's research capacity. The program establishes focal points of expertise that maintain and develop Australia's international standing in research areas of national priority.

A tax offset program that allows eligible companies to claim tax deductions for research and development activities conducted overseas. Companies must obtain an Overseas Finding before registering and claiming a tax offset for overseas R&D activities, demonstrating that the work cannot be conducted in Australia and meets specific scientific and cost conditions.

This grant scheme supports Australian participation in leading international collaborative research under Horizon Europe, the European Union's key funding program for research and innovation. It funds the Australian component of research projects that have been deemed fundable by the European Commission across selected health and medical research topics aligned with NHMRC's health priorities and international engagement strategy.

This grant supports medical research and medical innovation projects that promote Australian involvement in international collaborative investigator-initiated clinical trials through establishment and coordination of clinical trial sites in Australia. It funds research providing high-quality evidence of the effectiveness of novel health treatments, drugs or devices in 'usual care' settings to support decisions on delivering interventions in Australian settings.

This grant supports new, adaptive platform trials (Phase 2 or 3) in areas of unmet clinical need through international collaboration between Australia and the UK. The funding aims to invest in ambitious platform trials that support increased access to high-quality, evidence-based and effective health care. Joint project leads must be based in both Australia and the UK, with MRFF and NHMRC funding supporting the Australian-based arm of the trial.

This funding scheme supports high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health. The grants fund research proposals for clinical trials and/or cohort studies of any size, aiming to produce improvements in health and well-being, health care practice or policy through reliable evidence of health-related interventions and risk factors.

Investigator Grants provide consolidated funding for salary and research support to high-performing researchers at all career stages across biomedical, clinical, public health, and health services research. The grants offer flexibility for researchers to pursue new research directions, form collaborations, and adjust resources as needed rather than being restricted to a specific project scope.

An equity co-investment venture capital program that provides early-stage biomedical companies with investment to develop and commercialise biomedical discoveries. The fund supports therapeutic, medical, pharmaceutical products, processes, services, technologies and procedures that improve health and wellbeing through targeted investment in prevention, diagnosis and treatment.

The Biomedical Translation Fund provides capital to support groundbreaking innovation in Australia, helping commercialize research from universities and research organizations into commercial products. The fund addresses the 'Valley of Death' by providing a pool of $500 million ($250 million from the federal government and $250 million from private investors) to help innovative biomedical companies scale and achieve commercial success.

The objective of the Synergy Grant scheme is to: • support outstanding multidisciplinary teams of investigators to work together to answer questions that cannot be answered by a single investigator. The intended outcomes of the Synergy Grant scheme are: • multidisciplinary research that addresses major problems in all areas of human health and medical research, from discovery to translation. • highly collaborative teams of diverse researchers including by gender, career stage and cultural background, working together to address major problems in human health. Eligibility: Applications will only be accepted from NHMRC approved Administering Institutions. A list of NHMRC approved Administering Institutions is available at: https://www.nhmrc.gov.au/funding/manage-your-funding/nhmrc-funding/administering-institutions Applications must satisfy all the requirements set out in the Synergy Grants 2026 Guidelines. Total Amount Available (AUD): $55,000,000.00 Estimated Grant Value (AUD): From $5

The Medical Research Future Fund (MRFF) Emerging Priorities and Consumer-Driven Research initiative aims to enable or support research that improves patient care and translation of new discoveries, and encourage collaboration between consumers and researchers. Funding from this Initiative will support the development of new diagnoses, treatments and cures, and the translation of new discoveries into clinical practice. Three topics of funding are available based on the primary focus of the research or the geographic location of the organisation undertaking the majority of the research. The objective of this grant opportunity is to: Topic A (Aim 2 of Research Plan; TCR): improving the mental health of First Nations children through research led by First Nations researchers that includes meaningful involvement of First Nations communities. Topic B (Aim 2 of Research Plan; TCR): the organisation undertaking the majority of the research is based in any area according to the Modified Monash

This grant supports the 12 NHMRC-accredited Research Translation Centres to accelerate research translation into healthcare locally and across Australia. Funding supports centres to promote engagement between researchers and end-users, conduct research and research translation activities aligned with strategic objectives, and leverage further support from partner organisations to improve Australian health services and systems.

Competitive grants for organisations with specialist expertise in LGBTIQA+ health and wellbeing to support new and existing initiatives at local, regional and national levels. The program fosters access to appropriate, culturally sound and inclusive health care in line with the National Action Plan for the Health and Wellbeing of LGBTIQA+ People 2025–2035.

This grant funds cancer research focused on early-onset cancers, aiming to enhance understanding and develop novel clinical approaches for earlier diagnosis and innovative models of care. The initiative supports multidisciplinary collaborative programs that leverage existing research infrastructure and address causes, pathogenesis, early recognition, diagnosis, and management of early-onset cancers. Applications may focus on single or multiple tumour sub-types, with preference for cancers with greater disease burden.

Cochrane is an international, independent, not-for-profit organisation that aims to promote evidence-based practice in service provision and clinical healthcare. Cochrane systematic reviews are a key element in improving the quality and accessibility of the evidence to support healthcare decision making. The Australian Government has announced a total of $6,476,822 (GST exclusive) to support Cochrane activities in Australia over four years (from 1 July 2026 to 30 June 2030). This funding will be administered by the National Health and Medical Research Council (NHMRC).The objectives of this funding program are to:- Support Australian Cochrane review production and evidence synthesis to inform healthcare decision making.- Ensure that resources are allocated to specific, measurable activities that deliver high value outputs.For further information on the Cochrane Funding Program 2026, see the Cochrane Administered Funding Grant 2026-2030_grant opportunity guidelines. The activities that f

This grant supports medical research and medical innovation projects conducting clinical trials for rare cancers, rare diseases, and unmet health needs. It aims to improve the evidence base supporting clinical care, help patients access relevant trials, and enable researchers to bring international trials to Australian patients. The initiative funds four streams: pilot feasibility studies, clinical trials for rare conditions, trials supporting health technology assessment, and prevention clinical trials.

Synergy Grants support outstanding multidisciplinary teams of investigators to work together to answer questions that cannot be answered by a single investigator. These grants fund multidisciplinary research that addresses major problems in all areas of human health and medical research, from discovery to translation, with highly collaborative teams of diverse researchers working together.

This NHMRC grant opportunity funds implementation research addressing strategies for strengthening health systems to improve equity in high quality care and health outcomes, and reduce the prevalence and impact of non-communicable diseases. Research must focus on low- and middle-income countries (LMICs) and/or underserved populations such as Indigenous populations in high-income countries, with priority given to Australian Aboriginal and Torres Strait Islander communities in HICs.

This grant opportunity seeks to investigate short and long-term adverse health outcomes experienced by individuals living in unstable housing conditions. Research will inform the development of comprehensive interventions to improve health outcomes and reduce health disparities among people experiencing homelessness in Australia. Initiatives should foster collaboration among health service providers, academic institutions, researchers and communities with a holistic approach to health.

The NHMRC e-ASIA Joint Research Program supports Australian participation and collaboration in leading international research through the e-ASIA Joint Research Program (e-ASIA JRP). The e-ASIA JRP supports international joint research projects in the East Asia region. The e-ASIA JRP selects research projects through an open call for proposals. Fields of cooperation are decided among the e-ASIA participating member organisations and funding is for up to three years. The 2026 NHMRC e-ASIA Joint Research Program grant opportunity will support Australian participation and partnership in international collaborative research through the e-ASIA JRP 15th call for proposals in Health Research stream under the following topics: • Infectious disease and immunology • Advanced medical research and enabling technologies Further information on the e-ASIA JRP 15th Health Research call is available from the e-ASIA website Eligibility: Applications will only be accepted from NHMRC approved Administering

Supports Australian participation and collaboration in leading international collaborative research through the e-ASIA Joint Research Program on a multilateral basis. Funds research projects addressing either Infectious Diseases and Immunology or Advanced Medical Research & Enabling Technologies for up to 3 years.

Supports Australian participation in leading international collaborative research under Horizon Europe, the European Union's key funding program for research and innovation. NHMRC selects topics that align with health priorities and supports collaborative approaches to health and medical research internationally across multiple research areas including disease prevention, advanced therapies, and medical device innovation.

Supports Australian participation in leading international collaborative research under Horizon Europe, the European Union's key funding program for research and innovation. NHMRC selects topics that align with health priorities and supports collaborative approaches to health and medical research internationally across multiple research areas including disease prevention, advanced therapies, and medical device innovation.

Supports Australian participation and collaboration in leading international collaborative research through the e-ASIA Joint Research Program on a multilateral basis. Funding supports projects addressing Infectious Diseases and Immunology (including Antimicrobial Resistance) with up to 3 years of support. Projects must include collaborating partners from at least 3 member organisations across the East Asia region.

The CRE scheme provides support for teams of researchers to pursue collaborative research and develop capacity in basic science research, clinical research, health services research, and public health research. The scheme aims to improve health outcomes and promote translation of research outcomes into policy and/or practice, while supporting capacity building activities in the health and medical research workforce.

Grants of up to $2.5 million to support Australian medical research projects that use novel methods to harness multiple existing data infrastructure types to develop new approaches for addressing unmet medical needs. The program funds the creation or extension of national research data infrastructure that leverages at least two different types of existing research data sources (such as administrative data, biobanks, registries, and wearables with artificial intelligence).

A community benefit programme providing grants to support projects in the Kimba region. The programme funds a diverse range of community projects including infrastructure upgrades, economic development initiatives, youth and community services, and local business support.

This funding scheme supports collaborations between researchers and policy makers to define research questions, undertake research, interpret findings, and implement results into policy and practice. Partnership Projects address specific research questions to influence health and well-being through changes in the delivery, organisation, funding and access to health services.

The Partnership Project funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions, undertake research, interpret findings, and implement them into policy and practice. Partnership Projects answer specific research questions to influence health and wellbeing through changes in the delivery, organisation, funding and access to health services.

This program funds innovative projects that champion opportunities for women and girls in NSW, focusing on economic opportunity and advancement, health and wellbeing, and participation and empowerment. Funding supports projects aligned with the NSW Women's Strategy (2023-2026) delivered by majority women-owned and managed organizations.

A Commonwealth grant program supporting feasibility studies and projects in critical technology areas including quantum computing, quantum sensing, and advanced communications. The program funds collaborative projects between universities, research institutions, and industry partners to develop innovative solutions across energy networks, medical imaging, autonomous systems, and resource exploration.

A Commonwealth grant program that provides funding to support the establishment and operation of business incubators and accelerators across Australia. The program funds various types of incubation programs including regional incubators, sector-specific accelerators, and programs targeting specific entrepreneur demographics.

The MRFF Childhood Mental Health Research Grant Opportunity supports large-scale implementation research projects that bring evidence-based preventions and treatments into practice for children's mental health. Projects must be conducted in partnership with local health and community service providers, co-produced with children and families, and measure intervention impact while addressing implementation barriers.

The Ideas Grant scheme supports innovative research projects addressing specific health and medical research questions. It funds researchers at all career stages across any area of health and medical research from discovery to implementation, with expected outcomes including innovative and creative research.

This grant supports medical research and medical innovation projects conducting clinical trials across four streams: pilot studies for new clinical trials in rare cancers/diseases, clinical trials for rare cancers/diseases with unmet needs, clinical trials addressing evidence gaps for health technology assessment, and prevention clinical trials using early intervention strategies. The intended outcome is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality, evidence-based and effective health care.

This grant supports medical research and medical innovation projects that develop novel approaches to reduce treatment toxicity and adverse effects of brain cancer treatment for patients. The funding aims to minimize short- and/or long-term negative impacts for patients and carers, ultimately improving the health and wellbeing of Australians affected by brain cancer.

This grant supports medical research and medical innovation projects focused on cardiovascular disease and stroke prevention, clinical trials for novel devices and therapeutic approaches, and recovery trajectories in cardiovascular disease and stroke. Four streams are available: developing preventive health interventions for Aboriginal and Torres Strait Islander people, conducting Phase 1 and Phase 2 clinical trials, conducting large-scale multiomics projects, and developing novel therapeutics, risk prediction markers, and tailored preventive care approaches.

This grant supports medical research and innovation projects investigating post-acute sequelae of COVID-19 (PASC). Stream 1 funds small-scale developmental projects exploring molecular mechanisms, biomarkers, and prognostic factors of PASC. Stream 2 evaluates multidisciplinary, consumer-centred models of care for people with PASC, with specific topics addressing regional, rural, First Nations, disability, culturally diverse, and older populations.

This grant opportunity supports medical research and medical innovation projects focused on implementation research to improve quality of life for Australians as they age. Stream 1 funds research addressing inequalities in uptake of prevention activities for Aboriginal and Torres Strait Islander peoples, rural/regional/remote populations, and culturally and linguistically diverse populations. Stream 2 funds research to understand barriers and enablers to adoption of high-quality care for older Australians across different care settings and population groups.

This grant opportunity supports medical research and medical innovation projects across three streams: Stream 1 (Incubator) for early-stage research led by early career researchers, Stream 2 (Accelerator) for large-scale interdisciplinary programs led by mid-career researchers, and Stream 3 (Targeted Call for Research) for translating research into policy and practice. The grants aim to improve health and wellbeing of Australians by supporting researchers to develop innovative solutions and transform health practice for Priority Populations.

This grant opportunity supports medical research and medical innovation projects in two streams: Stream 1 focuses on developing and implementing pharmacogenomic approaches to identify new medicines and enhance medication efficacy across cancer therapies, antimicrobials, and other infectious or chronic diseases; Stream 2 conducts genomics research to optimise diagnosis, treatment, monitoring and prevention of high-priority diseases among Aboriginal and/or Torres Strait Islander peoples.

This grant supports medical research and medical innovation projects that promote Australian involvement in international collaborative investigator-initiated clinical trials through establishment of clinical trial sites in Australia. It funds research providing high-quality evidence of the effectiveness of novel health treatments, drugs or devices in usual care settings to support decisions on delivering interventions in Australian settings.

This Medical Research Future Fund (MRFF) grant supports medical research and innovation projects that develop consumer-informed approaches to incorporating patient data in health technology assessment across medicines, vaccines, and medical devices, as well as approaches to evaluating long-term effectiveness and safety of specialised therapies and implantable devices. The grant aims to improve health technology assessment decision-making and long-term health outcomes for Australians through better integration of patient-reported outcomes and real-world evidence.

This grant provides financial assistance to support medical research and medical innovation projects that develop scalable and sustainable interventions to mitigate the impact of climate change on Australians' mental health. Projects must be co-designed with consumers and health services. The anticipated outcome is to improve the health and wellbeing of Australians by addressing the mental health impacts of climate change.

This grant supports research into new ways to address preventive and public health issues in Australia, including risk factors and early detection, diagnosis and treatment of chronic and complex diseases. The research aims to improve health and wellbeing through three streams: improving prevention and management of perinatal mental ill-health, improving healthy development in early childhood, and promoting healthy lifestyle and preventive health approaches in adolescents, young adults and middle-aged people.

This grant supports medical research and innovation projects developing and delivering innovative, safe and effective stem cell medicines to improve health outcomes. It funds two streams: early stage clinical trials (Phase I/IIa) of new stem cell therapies, and research on ethical frameworks, regulatory approaches, community understanding, and health economics assessments for stem cell therapies.

The BEST Program provides funding to ex-service organisations (ESOs) to deliver compensation and wellbeing advocacy services to veterans and defence communities. The program supports ESOs in providing free advocacy services, improving the quality of claims to the Department of Veterans' Affairs, and promoting wellbeing services across Australia.